title: Effective treatment of antiphospholipid syndrome with plasmapheresis and rituximab.
abstract: With the exception of the catastrophic antiphospholipid syndrome (APS), the management of patients with APS has been largely supportive aiming at avoiding a recurrent thrombotic event; it is noteworthy that data concerning therapy targeting the triggering factor (the antiphopsholipid antibodies) are scarce. We report a case of APS manifested as recurrent fetal losses, ischemic stroke and renal dysfunction with concomitant nephrotic syndrome successfully treated with the combination of plasmapheresis and anti-CD20 antibody.
authors.forename: G
authors.initials: G
authors.lastname: Tsagalis
authors.forename: E
authors.initials: E
authors.lastname: Psimenou
authors.forename: L
authors.initials: L
authors.lastname: Nakopoulou
authors.forename: A
authors.initials: A
authors.lastname: Laggouranis